Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
Read transcripts of webcasts and audiocasts
Read transcripts of webcasts and audiocasts
Disclaimer: This is a machine-generated transcript and may contain inaccuracies.
Good morning, everyone, and welcome to Valmet. Valmet's third quarter 2026 results webcast. My name is Pekka Rouhiainen from Valmet Investor Relations. And with me today is our President and CEO. Thomas Hinnerskov. Valmet had strong orders and the Comparable EBITA increased in the third quarter. Next, Thomas will take you through the key highlights, what drove the results this quarter, and what it tells us about the strategic development of Valmet in the bigger picture as well. I will then cover the group financials, and Thomas will conclude on the outlook and key takeaways. And after the presentations, we will open the line for questions; as usual, you can submit written questions through the webcast platform to us at any time as well. Thomas, the floor is yours.
Thank you, Pekka. The central theme today is how customer value translates into Valmet performance. Let me start with the headline messages from the quarter. Four things stand out. First, orders received were €1.4 billion and increased 25% organically. The strength came from multiple sources. Biomaterial Solutions and Services grew broadly, Process Performance Solutions delivered growth, and Biomaterial Solutions landed some major project wins. Secondly, Comparable EBITA reached €169 million with a margin of 12.4%. This was a record third quarter result. Thirdly, both our net sales and comparable EBITA are now ahead of last year. Year-to-date, we reiterate our full-year guidance while recognizing that Q4 remains an important quarter for us. The third quarter gives us encouraging evidence of execution, but uncertainty and volatility in the market remain high. Finally, the strategic review announced this summer is progressing according to plan. The fundamental questions remain the same: whether the two businesses can create more long-term shareholder value independently than under the current combined structure. While no decision on a potential separation has been made, Valmet will initiate activities in Q4 to strengthen the segment's readiness to operate independently. We will provide an update at the latest in connection with our financial statements review for 2026. Now, let's step back from the numbers briefly to see why these results matter beyond the quarter. Everything we do at Valmet starts with one key question: how can we help our customers become more competitive? For our customers, competitive means running more reliably, producing more efficiently, using fewer resources, and operating with less manual effort. And the stakes are high. These are extremely valuable production assets. If a major plant goes down unexpectedly, the cost can run into the millions. So, reliability, productivity, and efficiency really matter to our customers. We help them improve each of these throughout the lifecycle of their assets. When we deliver an asset, our relationship with the customer does not end there. In many ways, that's where the lifecycle opportunity really begins. Over the years, we can support the assets through services and upgrades. That's why lifecycle growth is a central part of our strategy. It deepens customer relationships, increases recurring business, and reduces our dependency on the timing of capital projects. And this is the value creation model behind our 2030 targets of 5% organic growth, 15% Comparable EBITA margin, which equals 20% Comparable ROCE with the value creation model in mind. Let's look at how it translates into orders during this quarter. Orders received increased 25% organically to €1.4 billion. Importantly, this was not only a capital project story. The key highlight is that Biomaterial Services orders grew 12% organically, reversing the decrease during the first two quarters of this year. Process Performance Solutions also delivered 3% organic growth despite a low-growth market. In addition, major projects supported the quarter in Biomaterial Solutions and Services. We saw particularly strong order intake in China and Asia-Pacific, demonstrating our competitiveness in these markets. This reflects good execution by our teams across the businesses. I will now take the two segments in turn, beginning with Process Performance Solutions. Process Performance Solutions serves customers with automation and flow control that are critical to reliability, safety, and process performance. In a market characterized by low growth due to continued geopolitical uncertainty, orders increased 3% organically. That is a resilient outcome and reflects the mission-critical nature of our offering. I was particularly pleased to see the development in services and MRO. Reported orders increased 16% to €399 million, including €44 million from Severn, which we now call Engineered Severe Service to reflect the critical nature of the business. Customer decision-making in the business was affected by geopolitical tension during the quarter. This impacted demand, especially in the Middle East region, which is a reminder that visibility remains limited in parts of the market. Net sales increased 13% to €408 million and were stable organically. Comparable EBITA was €82 million, and the margin remained strong at 20.2%. The Severn acquisition was completed at the beginning of the quarter and integration is progressing according to plan. As we said when we completed the acquisition, this is primarily a growth and strategic positioning opportunity. Our focus is to combine the broad offering with disciplined execution to build the installed base and aftermarket opportunity over time. I am also pleased to be able to present the latest strategic milestone, which is the Manufacturing Execution System acquisition we signed yesterday. One way we can help customers become more competitive is by taking them further on the path of autonomous mills. That really is the rationale behind the MES acquisition. A manufacturing execution system connects production planning with real-time process control. In practical terms, it helps customers coordinate production, improve visibility, and move towards more autonomous mills. The acquired business brings an established platform with around 300 installations worldwide and approximately €32 million of annual revenue. It also creates recurring aftermarket opportunities through software maintenance and support. Strategically, the fit is clear and strengthens our already leading position in pulp and paper automation, making Process Performance Solutions even stronger. It also brings planning and process control together and gives us another way to create value across the customer asset lifecycle by building on Valmet's customer base, technology, and global reach. The transaction also creates long-term growth opportunities in process industries. I am also very happy that the standalone valuation was attractive for such a high-quality strategic asset. We expect to complete the acquisition during the second quarter of 2027. From automation, I will now move to our Biomaterial Solutions and Services business, where service growth and major project wins were defining the quarter. Biomaterial Solutions and Services delivered the strongest improvement in the quarter. Orders received reached €1 billion. Within that, Biomaterial Services orders increased 12% organically with broad growth across regions, service categories, and business areas. This is encouraging following early signs of stabilisation we discussed in the second quarter, although we still want to see the development continue before drawing broader conclusions. And why does this matter strategically? It matters because of biomaterials. We have the industry's largest installed base, serving those customers more broadly throughout the lifecycle of their assets. Their assets represent a significant long-term growth opportunity for Valmet, and this opportunity does not depend on customers continuously building new greenfield capacity; capital projects orders increased to more than €550 million. Major wins demonstrate our competitiveness in some of the customers' largest and most critical investments, including in China and Asia-Pacific. At the same time, large capital projects are inherently lumpy, and the timing of customers' investment decisions will continue to have a significant impact on market activity from one quarter to another. That's why we're working on rightsizing our production footprint, making our cost base less dependent on when the next large project is awarded. Net sales were €952 million and increased 1% organically. Comparable EBITA increased to €102 million and the margin improved to 10.7%. The improvements were supported by higher net sales and the benefits from efficiency and cost reduction actions. So we are seeing the first signs of a combination where we are targeting organic growth in services together with improved profitability. With that, I'll hand over to Pekka to take a closer look at the financial development.
Thanks, Thomas. Moving on to financials. We combined modest organic sales growth with a meaningful increase in earnings this quarter. Net sales increased to €1.4 billion, which was €66 million higher than in the comparison period. The reported increase included approximately €13 million of positive foreign exchange effects and €46 million from the acquired Engineered Severe Service. Organic net sales increased 1%, supported by 4% organic growth in Biomaterial Solutions and Services. Comparable EBITDA increased to €169 million and the margin was 12.4%. This was a record Comparable EBITA for a third quarter for Valmet. The improvement reflected the consolidation of Engineered Severe Service and the positive impact of efficiency and cost reduction actions under the Lead the Way strategy. The development of SG&A shows the structural side of the Lead the Way strategy. Since 2024, we have reduced our comparable SG&A cost base substantially over the last 12-month basis, excluding Engineered Severe Service. The reduction is €85 million. Importantly, these results reflect more than just cost reductions. The operating model renewal was designed to simplify the organization, improve accountability, and bring us closer to customers through a stronger life cycle. Focus. The lower cost base is therefore a result of structural improvements in how we operate the business, rather than short-term cost cutting. At the end of the quarter, the order backlog was close to €4.5 billion. That was €164 million higher than at the end of 2025, including the impact of Engineered Severe Service over the last 12 months. Book-to-bill ratio improved to 0.96 from 0.91 in the previous quarter. While it remains below one, the direction is encouraging, supported by the stronger order intake. Order intake in the third quarter was solid. Based on current delivery schedules, we expect roughly €3.7 billion of the backlog to be recognized as net sales in the fourth quarter of 2026 and during next year. Let me also give you an update on our landmark Arauco project in Brazil. As I know, this is important when you think about the backlog and its conversion. The project is proceeding according to plan and schedule and we are now approximately 70% complete. The startup is expected in the second half of 2027. We recognized approximately €400 million of net sales from the project in 2025, and approximately another €400 million during the first nine months of this year. As we have said previously, we expect approximately €500 million of net sales for the project for 2026 as a whole, and the backlog provides visibility for upcoming deliveries. Our focus for the remainder of the year remains on disciplined execution, profitability, and cash generation. But with that, let's now turn to the cash flow. Cash flow improved clearly in the third quarter. Cash flow from operating activities increased to €210 million, and free cash flow increased to €183 million. As we expected in the second quarter, cash conversion improved from 62% to 79% on an LTM basis. At the same time, underlying net working capital remains elevated, excluding the €123 million dividend liability. Net working capital was €138 million higher than at the year-end. Part of this relates to Engineered Severe Service, but we continue to see opportunities to improve working capital efficiency. Our balance sheet remains healthy. Also after the Engineered Severe Service acquisition. Net debt increased by €239 million from the end of the second quarter to €1.2 billion, mainly because the acquisition was completed during the quarter. Gearing increased to 47% and remained below our financial target of 50%. Net debt to EBITDA was 1.78. Following the Engineered Severe Service acquisition, our focus is on strong cash flow generation. At the same time, our balance sheet continues to give us flexibility to pursue attractive bolt-on acquisitions when we see opportunities that fit the strategy. The Manufacturing Execution System acquisition we completed after the end of the quarter is a good example of this. The average interest rate on total debt was 3.6%, unchanged from a year ago. This leads us directly to returns on capital. Capital employed increased following the Engineered Severe Service acquisition, while Comparable ROCE remained broadly stable at 12.9% on an LTM basis; adjusted earnings per share was €1.86, slightly up from the full year 2025. Our 20% Comparable ROCE target is important because growth alone is not enough. When we invest capital, whether organically or through acquisitions, we need to generate attractive returns on that capital. And with Engineered Severe Service, we have deployed additional capital. Our task now is to integrate the business successfully, capture the top-line synergies, and make that capital work for our shareholders through higher earnings and, over time, higher returns. This is why our 5, 15, 20 targets belong together. We need organic growth of 5% and a comparable EBITA margin of 15%, while remaining disciplined in how we use capital to reach our 20% Comparable ROCE target. So before I hand it back to Thomas, let me bring the quarter and the first nine months together in one set of key figures here. The third quarter was stronger than the year-to-date development. In several aspects. Orders received increased 30% in the third quarter, while net sales increased 5% and Comparable EBITA increased 6% for the same period. Net sales are now up 5% and Comparable EBITA up 3%, while orders received were 2% below the comparison period. Let me also highlight a few items below. Comparable EBITA. The items affecting comparability were -€25 million in the quarter and -€59 million in the first nine months. These were mainly related to efficiency and cost reduction actions under Lead the Way. Going forward, we expect to incur approximately €10 million of costs related to activities in Q4 2026 to strengthen the segment's readiness to operate independently, moving further down the income statement. The effective tax rate was 29.3% in the first nine months, which is above our long-term average level. Our tax rate can fluctuate between quarters due to profit mix and timing effects, so individual quarterly tax rates should not be considered indicative of the level going forward. Our longer-term average effective tax rate has been approximately 25%, together with higher financing expenses. These items explain the difference between the development of Comparable EBITA and the reported earnings and EPS. With that, I hand it back to Thomas.
Thank you Pekka. I will now turn to our guidance and the short-term market outlook. We reiterate our guidance issued in February this year. Valmet continues to estimate that net sales in 2026 will remain at the previous year's level and that Comparable EBITA will remain at the previous year's level or increase compared to 2025. Turning then to the market outlook for Process Performance Solutions, we continue to expect the market to remain at a low year-on-year level of growth. The segment has demonstrated good resilience throughout the nine months of the year. At the same time, uncertainty related to the geopolitical situation and the global economic outlook remains elevated and continues to reduce short-term visibility for Biomaterial Solutions and Services. We expect the market to remain broadly unchanged. This should not be interpreted as an expectation that the strong Q3 capital order intake will repeat. in biomaterial. Capital order intake can vary significantly between quarters due to the timing of large customer investment decisions. For Biomaterial Solutions and Services, we continue to expect the market to stabilize in the coming quarters. The strong growth we saw in Q3 was encouraging, but we would not extrapolate one quarter's growth rate into the next. As we enter the final quarter, year-to-date Comparable EBITA is slightly ahead of last year. However, Q4 remains an important quarter for the full-year outcome. Profitability will depend particularly on service activity and execution, while market visibility remains limited. Let me finish where I started with our customers. Our ambition is to help them become more competitive throughout the life cycle of their assets. This quarter gives us encouraging evidence of progress in the direction we have set. Service business. Broadly, we. One major capital project is underway, including in Asia and China. Our Process Performance Solutions business continued to grow organically and our Comparable EBITA reached a record level for the third quarter. Our focus remained clear, creating more value for our customers across the life cycle, driving cost competitiveness, strengthening our business, and with these, improving our financial performance. With that, I will hand back to Pekka.
Thank you, Thomas. So now we will move to the Q&A session, and you may submit written questions through the webcast platform. Participants on the conference call may also ask a question by following the operator's instructions. Let's begin with the webcast platform. As I see we have a question on the platform. I will read it out loud. It is by Mark Moylan from Nordea regarding the planned separation of the businesses. Is the plan to do balance sheet refinancing as part of the process, or is the plan to split the outstanding debt to the separate companies? Could you please discuss this?
Thank you, Mark. It is a bit too early to talk about the whole capital structure. Should we potentially end up splitting into two separate companies? It is of course important to be very clear about that. Should we demerge the company into two? We need to make sure that each of the companies has a capital structure that actually supports the strategic direction. That means that in Process Performance Solutions, we should have room for bolt-on M&A. In Biomaterial Solutions and Services, we will need to be able to finance the working capital development, especially with the move towards a more aftermarket and service business that we are shifting toward. That does tie up more net working capital. However, it also means that the fluctuation in net working capital will be lower between the quarters. So less need for having big buffers there.
All right. Thank you, Tomas, for the clear answer. There are no more questions at this stage in the written platform. Please use that opportunity as well if you have questions. But with that, let's move to the conference call lines.
If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial pound key on your telephone keypad. The next question comes from Antti Kansanen. From SEB. Please go ahead.
Hi. Thank you for taking my questions. I have two questions. If we start with the first question. It was nice to see the good growth on the Biomaterial Solutions and Services side. So, could you provide a bit of color on that front? Were you able to defend the good level of mill improvements from last year, or was the growth predominantly driven by recovery on the parts and consumables side? So Thomas, maybe a little bit of color on that front.
Yeah. Great. Thanks for listening in. I think we were also very happy with the 12% organic growth in services. What I think, which also gives me good confidence, is that it was actually broadly based, both geographically and across the different services that we are providing. We saw good demand in consumables and parts, improvement projects, and an increase in field service activity. And that was across the different geographies. So, it was very broad-based overall.
Is there any reason why you remain a bit cautious regarding the sustainability of this level? So, do you suspect that there was some type of pent-up demand or recovery on some parts of your clients, or was it more in line with their actual utilization rates and business needs?
Yeah, it's a good question, Antti. It is always difficult to take one data point and then extrapolate that across quarters. We still see this trend, and we have seen it throughout this entire year. I think we have been pretty good at predicting it still. But there is lower visibility. What we have seen historically, I would say, is that last year in 2025, there were a lot of closures across, especially, North America. Where was it? Was it roughly 19 million tons or something that closed off. We think we had roughly 7.5 million tons of that this year. Another 7 million closed. We had less than two of that. That is a positive. So that has meant that we've seen operating rates come up. And also, overall production volumes are slightly above last year, which I think is also positive to see that the underlying demand for our customers and products is improving.
Okay.
Fair enough.
And then the second question, which is actually the second and third question now that I think of it, is on the demerger side and actions that you are now starting in Q4. So is this something that you are redistributing some of the functions from group items to the segments? Or is this something that will actually increase your run-rate operating costs after the one-off actions? I am not referring to the 10 million. One-off, but starting from next year.
Now. Yeah. What we are going to do now, starting here in Q4, is really to take some actions that will help us operate these two segments independently. So it really is about simplicity in the processes and also in the systems.
But is this something that is adding to your cost run rates, or are you just shifting people around?
It is not so much about the people. It is more about the systems and processes. And what we are doing now in Q4 is not going to impact negatively. I would say run rate cost into the new year.
Okay. And then the second part of the question is that obviously no decisions have been made yet, but thinking about the investments that you are now doing in Q4. It kind of indicates what would happen. So what would actually need to happen for you to walk away from this demerger? The demerger plan, given that you are now investing into that strategy already with 10 million.
Yeah. As we have noted, there was clear merit for these two segments to operate more independently. All the way back when we revised the strategy and operating model back in June 2025. Now we are taking that a step further. Of course, we are still doing diligent work on whether we will create more value for shareholders if these businesses were independent? How does the synergy potential look? And will we face some tax issues that we need to evaluate against the potential benefits? So it really is about confirming the upside from a shareholder value creation perspective of running these businesses strategically independently, and whether there are bigger roadblocks in terms of dis-synergies and tax that we need to factor into that evaluation.
All right. Thank you very much.
Thanks, Antti.
The next question comes from Panu Laitinen from Danske Bank. Please go ahead.
We cannot hear you.
Panu Laitinen, McKee. Your line is now unmuted. Please go ahead.
Yes. Sorry. Can you hear me now?
Yes.
Yeah. Apologies. So I have a few questions starting from Process Performance Solutions. How much roughly did the acquired Engineered Severe Service contribute on the earnings side? And assuming the contribution was positive, the organic earnings seem to be down year on year. So what are your expectations in that business in organic terms going forward? So, basically two questions for Process Performance Solutions.
Yeah. So we had 44 million of sales for Engineered Severe Service. And in this past quarter. This was the first quarter where they have been included into Valmet, and the profitability level of those sales was in line with what they have delivered historically as well. So you can incorporate that into your model. Then it is also clear that this is lower compared to, if you average out the overall order intake and their net sales run rate, they have been impacted by the fact that there have been fewer or no large projects this year, and particularly impacted by the Middle East situation in glocal markets. But also valve technologies have been impacted by that and have not seen large projects this year. I would also say this is something we knew when we acquired them, that they do have a more lumpy business model where large projects come and go. There is a difference between the years. We are still very positive that they have joined the Valmet team and we are really exploring and starting to see some of the first top-line synergies in terms of orders received as the teams come together and the offering expands. So good. I would say good traction on the integration so far.
Okay. Thank you. Then on the Biomaterial Solutions and Services, the earnings improved sequentially quite a bit from Q2. So was this primarily from higher service sales, or was the equipment profitability better? Or did you get more cost savings than in Q2?
Yeah. I think it is a mix of the above, I would say. We did have higher service sales for the quarter. We have also continued to drive structural efficiency, and we have also taken actions this quarter. That is also why you see some of that 25 million below the EBITA. That is actually because of having driven further efficiency improvement in the business, which of course will give us further tailwind going into the new year. So, there is a mix, there is capital, but then there are also structural cost savings, including the initiative that we have taken on global supply, which really got up to speed early this year, and where I am quite happy that we can already say that we are ahead of our own plan on that strategic initiative.
All right. Thank you. My final question is on cost inflation. So how should we think about that going into Q4 and perhaps beyond? Do you see more incremental pressure from that, or are you able to price that in, or what are your thoughts going forward?
Yeah. It is clear. I mean, the inflationary pressure has been something that we felt this year. And that is also why it has been really good that we had that global supply initiative, because that has been driving savings. And of course, then also the whole commercial excellence initiative that we also presented during our Capital Market Day last year, where pricing, of course, comes into play in all our businesses in order to mitigate and keep margins from contracting. Right. You can also see that in Process Performance Solutions with continued good margins. Right?
All right. Thanks. That is all for me.
Thanks, Paul.
The next question comes from Christophe Belfort from BNP Paribas. Please go ahead.
Good morning. Thank you for taking my questions. I have two questions, please. You have recently announced some larger capital projects coupled with a service package. Can you give us some indication about the size of the service package as a percentage of total capital sales? This is number one. And number two is on the election of Mr. Lula in Brazil. Do you expect any positive or negative implications for capital projects in the country? And if you could just remind us of the revenue contribution in Brazil, excluding the project, this would be helpful as well. Thank you.
Thanks, Christoph. In terms of the service package that comes with the capital projects, you cannot fully generalize that, as it varies from project to project and from technology to technology. Also, it depends a little bit on the region, but it is more about what we are actually going to deliver. But it is of course clear that with our lifecycle approach, we do try to tie up a service package as we sell the capital. But then also, even more importantly, it is about making sure that we help the customers after start-up, really to optimize the total cost of ownership and the operational cost and the efficiency after that. That is really where the lifecycle comes into play. On the Brazil election, I think it is still early days. You have, of course, seen some impact on interest rates. But I think it is hard to say at this stage if that will have any impact on the investment decisions in Brazil. I probably doubt that it will have an impact in the short term, but it is still early days.
And then regarding the Brazil contribution to the total net sales. Well, obviously the project being now $400 million into this year is a big part of those net sales; we are not reporting Brazil separately, but even from the Latam net sales, it obviously is a big part of that. But we have a big business in the services side. Every year in the Latam region, on top of the now ongoing project.
Thanks a lot.
The next question comes from Sven Weyer from UBS. Please go ahead.
Yeah. Good morning. It is Sven from UBS. Thanks for taking my questions. I will ask them one at a time. The first one is a question regarding China. I believe you received one project in the country. And I was wondering what you think is the remaining runway for such pulp integration projects in China. I mean, this has been going on for some time now. What is your confidence in this actually continuing for the quarters to come? That is the first one. Thank you.
Yeah. We were quite happy. We remain quite selective on some of these projects. And that is also part of this whole rightsizing of our supply chain and footprint in our global supply, so that we actually can afford to be selective on which projects we really go for and which ones we are less keen on. There has been lots of talk about China and especially the pulp market or the pulp investment into integrated mills there. I think it is difficult to predict the future regarding that. There is still good, strong interest from a lot of customers to continue doing this. They obviously get some benefit from the energy side of things as well as the efficiency of having integrated mills, but it is hard to predict the real short-term or the next 6 to 12 months outlook on that, although I would have to say it is the same customers. Sorry. Once again.
Sorry, I was just going to say that. In the short term, there's still a good pipeline for such projects.
As you know, Chinese players have talked a lot about this and are warming up to it, and there are still projects to be considered and looked at. We are, of course, part of that review together with our customers. But when it comes to timing, it is definitely hard to predict in terms of quarters.
Understood. Thomas. My second question is regarding the strategic review. I was just wondering if you could share with us whether, since you announced the decision to conduct the review, you have received any potential interest from strategic buyers for any of the divisions?
Yeah. So, of course, as you know, we've announced the strategic review, and we were relatively clear about that. This is a review about a potential demerger spinning into two separately listed companies. So, that is the hypothesis that we are continuing to work on. It is clear that we have some attractive assets and there could be interest in looking into this from other parties, but right now we are pursuing the demerger and the two separate listed company opportunity and reviewing that as a potential value creation for our shareholders.
That is not a no regarding whether you received any interest.
We would not comment on whether we had or had not received such interest. Right. So it is an answer to the question as good as I can provide it.
Thank you Thomas.
The next question comes from Michael Doble from Nordea. Please go ahead.
Thank you. Good morning, everybody. A couple of questions. So firstly, on the pulp and paper aftermarket business. As you mentioned, the growth was quite strong in the quarter. I'm just wondering, do you have any market intelligence on market shares? Does this strength also reflect you gaining market share in the quarter? And perhaps also, since the strategic update a year and a half ago, I think you have outlined your intention to grow this business at twice the historical pace. I'm just wondering, since then, have you seen any changes to your market shares overall as well?
Yeah. It is always difficult to track, and we do not really look at market share, especially on a quarter-by-quarter basis. We have to take a longer view on that. But I think it's safe to say that I don't think the market grew 12% in Q3, but you need to have a little bit longer views on that in order to really calculate the market share. Then as you said, at the Capital Market Day in 2025, we stated that we want to grow services by 8%, which was really driven by market growth, volume growth, pricing, and then taking share. Right. And that is still our ambition level, and we continue driving for that. And this is also where the commercial excellence strategic initiative is very important so that we become much better at understanding how we can help our customers because we have this large installed base. So how can we help our customers? Improving that and actually therefore being more competitive in their market, for example, take the North America installed base. We have two-thirds of the board and paper mills in North America. They are in our installed base. Right?
Right. Okay. And then secondly, if you look at the project pipeline overall, I know you mentioned in your opening remarks that projects and these bigger deals can fluctuate from quarter to quarter. But maybe you could talk a bit about the pipeline currently. You mentioned already in the previous question about the China situation, but what about elsewhere? Latin America? How would you describe the overall pipeline that you have and the level of activity there?
Yeah. Good question. I think overall, we have good activities with our customers, helping them articulate projects, looking into them, and analyzing them. It is also fair to say that the decision-making process has prolonged over the last 18 months, I would say, due to the geopolitical situation that we have had, which makes it more difficult for our customers to predict the future and consequently drags out the decision-making process as well. And it is harder to predict when the decisions are going to happen, right? But overall, I think there is good activity in the market, but it is just difficult to predict when things come to signing, so to say.
Right. Would you say that activity levels have improved in the past couple of quarters?
We have actually seen the same level, I would say, across this year, but it has good levels. There are lots of good conversations and active discussions. It just comes in very lumpy, as we have also seen that Q1 was very quiet, followed by good performance in Q2 and Q3.
Right, right. Okay. Makes sense. Thank you very much.
Thanks.
The next question comes from Antti Kasanin from SEB. Please go ahead.
Yeah. Hi guys. Thanks for taking my follow-ups. First is on the Automation Solutions order side this year. Could you perhaps open up a little bit more on the industries where you have taken orders this year, what is the current run rate on paper exposures, and which industries have contributed the most, excluding that one?
Yes, that is a good question. I think we have generally had a very resilient year overall in Automation Solutions. The business part that has been struggling this year has been our analyzer products and integration. So our gas chromatography business is primarily seeing a lot of impact from the Middle East crisis. That is the segment we have seen down for the year where we would actually have expected growth when we started the year. That has been coming down primarily due to the Middle East. The others are quite resilient and it is positive to see.
And any comments on the share of pulp and paper, which I guess was 50% in 2025. That share has dramatically shifted.
No, that is not the case. I mean, we have a very large service base in that part as well. So that is relatively stable for the year.
Okay.
And then the second question was on the Chinese pulp mill deal that you booked for the quarter. I mean it is a big mill, 100 million for you guys. Do you have any comments on this? I would assume that there is a smaller scope in terms of the project responsibilities and things like that. Could you provide any indication on the margin potential for that, if you compare it to a large mill project in Latin America, and also the aftermarket potential for you over the long term.
Yeah. I mean, as you know, we don't really comment on individual projects generally and definitely not the profitability level there. But clearly, we are a pure technology provider in China. No, nothing additional in terms of installation responsibility, etc.
Okay. But structurally, if you look at your business in China, as I said, regarding the provider, what about pricing power, competition, and cost competitiveness? Is that similar overall, or is there more intense competition from local competitors?
I think it is important to reflect on that. Depending on where you operate in the world, there are different parameters for how you win that game, right? In order to be competitive in China, you do need to have a fair amount of Chinese-manufactured components, both from a cost-competitive point of view and regarding logistical costs. So that is where we have worked quite a bit with our global supply chain in the last nine months in particular. And that has improved our competitive situation in China as well.
Okay. And then, the aftermarket potential in the pulp market versus the rest of the world. Do you have any views on that?
Yeah. So. You have to consider what we do service-wise in different geographies, as in certain markets, we have more field service than in others. Certain markets we do fabrics, which we don't really do much of in China. So, the fabrics business is not a big thing for us in China because we simply do not have that local manufacturing capability. So that becomes a smaller part than it does in other parts of the world; still, it is a good service business, particularly with our own design items, which becomes proprietary technology that then also goes into the spare parts and consumables there.
So the opportunity is obviously a win-win also. Also, aftermarket services in the China market are significant. In the China Capital DLC, even if the. Even if the opportunity might be a little bit smaller in size compared to some others, it is a good service market for Valmet.
All right, that's very clear. Thank you very much.
Thanks.
The next question comes from Panu Mäki from Danske Bank. Please go ahead.
Hi.
Thanks for taking my follow-up. I just wanted to ask about the order backlog. Martin. So you provided this information about the order backlog, indicating that you will deliver a bit more next year than what you expected a year ago. But what about the margins in the order backlog? Are they similar to what you had earlier? Are they better or lower? Just directionally, is the mix impact beneficial, or is it represented differently as part of the backlog than it used to be and so on. So any comments there?
Well, the backlog is generally a healthy, good backlog. It is very difficult to give more exact comments on the margins on that side; we will provide the 2027 guidance in connection with the Q4 results.
All right. I will wait until then. Thank you.
There are no more questions at this time. So I hand the conference back to the speakers.
All right. Thank you. We still have a few more questions here on the platform. So we will take the next question from Sandra. How is the current situation in the Middle East affecting flow control, particularly in terms of customer demand, order intake, and project activity.
It is clear that we have some direct impact from the Middle East situation in terms of both projects that are on hold or not being executed, as well as the entire service side of things. That is, of course, when the assets are not running and you do not have access to them. So it does have a negative impact overall for Flow Control, as I just said, and it also has an impact on our energy business in Automation. So there is clearly a direct impact on the Middle East situation. Then there is also, I would say, an indirect impact in terms of the increased geopolitical tension that makes a lot of the project and capital decisions sort of prolonged in terms of process.
Thank you Thomas. And then moving on to questions from Lacey, from Bloomberg. The first question is on the order backlog conversion. You mentioned roughly 3.7 billion of backlog converting through the fourth quarter and 2027 as net sales; as the Arauco contribution rolls down, how much confidence does that give you for the 2027 revenue base, and where does the remaining gap need to be filled from new orders? So, what are the net sales drivers for 2027?
Yes, of course. It is a bit early to give guidance for 2027 overall, but it is also clear that, of course, the Arauco project will come to an end during the second half of 2027. So that revenue will fall away. And then, we do need to drive growth. We will, as we normally try to, and this is where I think it is important to remember that we really are. If you think about two parts, right? There's the part with a great margin; it really is just about how can we drive growth? If the geopolitical situation eases up, in particular in the Middle East, and there is access and the assets start to be up and running again, that will give us some opportunities. Then in the Biomaterial Solutions and Services, we talk a lot about the project, but it really is about how we guide the business to be a much stronger aftermarket business that really helps our customers with the installed base. There are a thousand installations just in Europe. So one or two more somewhere else in the world. That is not going to make a significant difference. It really is about how do we drive the aftermarket demand and help our customers back to being more productive, more efficient, and more competitive in their market?
Thank you, Thomas, for the clear answer. And then another one from Lacey. At this stage, this is the last question. So on the Biomaterial Solutions and Services margins which improved, can you help us separate the benefit from the sales volumes and then from the structural savings from Lead the Way and global supply? And then also, which of these are recurring going into 2027?
Yeah. I mean, the improved MES margin is a combination of all these things; it is about improved margins, but it is also about improved mix. We have benefited from the volume. And that is also once you get the service volume up to a certain level, then the drop-down rate just flows through, right? It does not drive additional structural costs. So that is also why it is so important that we drive that service volume. But it also becomes a swing factor overall in terms of the bottom line. Right. And then global. Then we have the structural improvements. We really started strongly last year. And we benefited from that this year. We have driven further structural improvement now in Q2 and Q3, going into October as well, which will give us further efficiency improvements in 2027 for global supply. Overall, I am happy to say that we are ahead of the plan there, and that makes us competitive. So we, among other things, can win these Chinese projects as an example, but also that we overall can mitigate cost inflation and expand margins.
Great. Thank you. Thomas. Thank you for the good questions from the audience. I guess that is it from the Q&A side. No further questions here. So, Valmet's Financial Statements Review 2026 is scheduled for February of next year. We will also provide an update, as discussed, on the strategic review at the latest in connection with the publication of those results. And if you have follow-up questions, please contact us at Investor Relations. But now I hand it back to Thomas for any final remarks.
Thanks, Pekka, and thanks to all of you for joining us today and for your continued interest in Valmet. I would also like to thank our customers for their trust and all our Valmet employees for their commitment and hard work throughout the quarter. So we are clearly making progress, but there is still a lot to do. It is very comforting for me to know that the focus remained the same. It remains clear that it is creating more value for our customers across the life cycle, driving cost competitiveness, strengthening our business, and with these, improving our financial performance. Thank you for all your attention. Have a great day and hope to see you soon. I hope to see many of you again soon.



















